The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
FDA Commissioner Robert Califf has called misinformation one of the deadliest killers in the United States. As the FDA tries to fight that scourge, it sometimes stumbles.
Even as the covid-19 pandemic wanes, litigation — whether about vaccines, masks, or a range of other public health policies made during the pandemic — isn’t about to end.
Twelve of the largest drugstores in the U.S. sent shoppers’ sensitive health information to Facebook or other platforms, according to an investigation by The Markup and KFF Health News.
The views of the leader of a broad anti-vaccine movement who is now running for president are unchallenged in public forums run by several prominent Silicon Valley figures.
Some GOP members of the House Select Subcommittee on the Coronavirus Pandemic have two-stepped around vaccine skepticism, proclaiming themselves to be pro-vaccine while also validating the beliefs of people who oppose vaccine mandates. The result could have serious public health consequences.
Las empresas quieren que sus IA tomen notas para los médicos y ofrezcan una segunda opinión, suponiendo que puedan evitar que divulgue la información privada de los pacientes.
Giant corporations like Microsoft and Google, plus many startups, are eyeing health care profits from programs based on artificial intelligence.
La competencia para hacerse con un mercado que podría valer $100.000 millones al año, solo para los fabricantes de medicamentos, ha desencadenado una ola de publicidad que preocupa a las autoridades sanitarias y médicos de todo el mundo.
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
This year’s JPMorgan confab, the first since covid’s chilling effect on such gatherings, was full of energy and enthusiasm. But it was also marked by questions about the future of health care investment.
As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.
Con un surgimiento de las infecciones de transmisión sexual, trabajadores de salud pública encuentran en los apps de citas un espacio ideal para mensajes de prevención y rastreo de contactos.
For contact tracers of sexually transmitted diseases, telephones and text messages have become ineffective. Dating apps increasingly are their best bet for informing people of their exposure risks.
Muchos estadounidenses han recurrido a la última gran idea para perder peso; ya sean dietas de moda, la obsesión por el fitness, hierbas y píldoras poco fiables o la cirugía bariátrica. Parece que nunca acaban siendo la solución mágica con la que la gente sueña.
A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?
Veterans Affairs’ electronic health records aren’t friendly to blind- and low-vision users, whether they’re patients or employees. It’s a microcosm of America’s health care system.
Medical records can contain seemingly objective descriptions that are actually full of coded language and subtext. How does that affect care?
Work-based benefits may expand access to abortion for people who live in areas where the service is unavailable, but experts warn that claiming benefits could create a paper trail for law enforcement officials to follow.